|

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

RECRUITINGSponsored by Tempus AI
Actively Recruiting
SponsorTempus AI
Started2022-06-21
Est. completion2027-02
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations20 sites
View on ClinicalTrials.gov →

NCT05234177

Summary

The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Known or suspected colorectal adenocarcinoma (Stage I to IVA disease)
* Planning to undergo or has undergone a surgical resection for suspected adenocarcinoma of the colon or rectum with curative intent.
* 18 years old or older
* Willing and able to provide informed consent
* Willing to have additional blood samples collected during routine surveillance visits

Exclusion Criteria:

* Not willing to have additional blood samples collected
* Pathology that is not consistent with colorectal adenocarcinoma

Conditions2

CancerColorectal Cancer

Locations20 sites

Mercy Clinic Oncology - Fort Smith
Fort Smith, Arkansas, 72903
Billy CaterBilly.Cater@mercy.net
MemorialCare
Fountain Valley, California, 92708
Laura Macias562.706.2701LMacias@memorialcare.org
The Center for Cancer and Blood Disorders
Bethesda, Maryland, 20817
Kosunique Jenkins301-571-2016kosunique.jenkins@tempus.com
Mercy Clinic Oncology and Hematology - Joplin
Joplin, Missouri, 64804
Cynthia MeyerCynthia.Meyer@mercy.net
Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center
Springfield, Missouri, 65804
Jennifer HyltonJennifer.Hylton@mercy.net

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.